Illumina, Inc. Insider Trading

ILMN

Last 12 months

Insiders bought 24K and sold $593M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Keith A. Meister sold $148M on Aug 5, 26% of their stake, outside a plan.

Net open-market

−$593M

1 buy · 18 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 5

executives and directors

Last open-market buy

Feb 2026

Feb 9, 2026

Get an email when ILMN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 2 – 4	Keith A. Meister Director	SoldNo plan 12 parts	263,560	$217.03 average	$57.2M	25%	Form 4
Aug 25 – 27	Keith A. Meister Director	SoldNo plan 13 parts	375,941	$226.74 average	$85.2M	27%	Form 4
Aug 19 – 21	Keith A. Meister Director	SoldNo plan 28 parts	679,574	$214.19 average	$146M	32%	Form 4
Aug 18	Christensen Jakob Wedel SVP, Strategy/Corp Development	Sold10b5-1 plan	1,033	$191.52	198K	6.9%	Form 4
Aug 4 – 5	Keith A. Meister Director	SoldNo plan 14 parts	741,127	$199.91 average	$148M	26%	Form 4
Jul 30	Scott M Davies Chief Legal Officer	Sold10b5-1 plan	615	$200.00	123K	2.9%	Form 4
Jun 25	Scott M Davies Chief Legal Officer	Sold10b5-1 plan	615	$180.00	111K	2.9%	Form 4
Jun 5	Patricia Leckman SVP, Chief People Officer	Sold10b5-1 plan 5 parts	783	$162.59 average	127K	3.6%	Form 4
Jun 2	Patricia Leckman SVP, Chief People Officer	Sold10b5-1 plan 3 parts	784	$162.08 average	127K	3.4%	Form 4
May 28 – Jun 1	Keith A. Meister Director	SoldNo plan 17 parts	669,596	$159.86 average	$107M	19%	Form 4
May 29	Scott M Davies Chief Legal Officer	Sold10b5-1 plan	615	$160.00	98K	2.8%	Form 4
May 28 – 29	Scott D Ericksen VP, Chief Accounting Officer	Sold10b5-1 plan 2 parts	2,000	$152.58 average	305K	12%	Form 4
May 13 – 14	Keith A. Meister Director	SoldNo plan 9 parts	329,460	$145.49 average	$47.9M	8.6%	Form 4
May 6	Christensen Jakob Wedel SVP, Strategy/Corp Development	Sold10b5-1 plan	700	$139.04	97K	4.4%	Form 4
Feb 20	Scott M Davies Chief Legal Officer	Sold10b5-1 plan	1,336	$116.18	155K	7.6%	Form 4
Feb 18	Patricia Leckman SVP, Chief People Officer	Sold10b5-1 plan	2,370	$116.18	275K	13%	Form 4
Feb 9	Scott Gottlieb Director	Bought	200	$117.81	24K	1.6%	Form 4
Dec 12, 2025	Scott M Davies Chief Legal Officer	Sold10b5-1 plan	323	$136.09	44K	1.8%	Form 4
Dec 8, 2025	Christensen Jakob Wedel SVP, Strategy/Corp Development	Sold10b5-1 plan	549	$129.27	71K	4.8%	Form 4
Nov 3, 2025	Scott Gottlieb Director	Bought	500	$122.13	61K	4.2%	Form 4
May 12, 2025 – May 13, 2025	Jacob Thaysen Chief Executive Officer	Bought 7 parts	12,350	$80.86 average	999K	17%	Form 4
May 12, 2025	Ankur Dhingra SVP, Chief Financial Officer	Bought	6,100	$81.21	495K	32%	Form 4

Sep 2 – 4No plan
Keith A. Meister
Director · sold 263,560 at avg $217.03
$57.2M
25% of stake
Aug 25 – 27No plan
Keith A. Meister
Director · sold 375,941 at avg $226.74
$85.2M
27% of stake
Aug 19 – 21No plan
Keith A. Meister
Director · sold 679,574 at avg $214.19
$146M
32% of stake
Aug 1810b5-1 plan
Christensen Jakob Wedel
SVP, Strategy/Corp Development · sold 1,033 at $191.52
198K
6.9% of stake
Aug 4 – 5No plan
Keith A. Meister
Director · sold 741,127 at avg $199.91
$148M
26% of stake
Jul 3010b5-1 plan
Scott M Davies
Chief Legal Officer · sold 615 at $200.00
123K
2.9% of stake
Jun 2510b5-1 plan
Scott M Davies
Chief Legal Officer · sold 615 at $180.00
111K
2.9% of stake
Jun 510b5-1 plan
Patricia Leckman
SVP, Chief People Officer · sold 783 at avg $162.59
127K
3.6% of stake
Jun 210b5-1 plan
Patricia Leckman
SVP, Chief People Officer · sold 784 at avg $162.08
127K
3.4% of stake
May 28 – Jun 1No plan
Keith A. Meister
Director · sold 669,596 at avg $159.86
$107M
19% of stake
May 2910b5-1 plan
Scott M Davies
Chief Legal Officer · sold 615 at $160.00
98K
2.8% of stake
May 28 – 2910b5-1 plan
Scott D Ericksen
VP, Chief Accounting Officer · sold 2,000 at avg $152.58
305K
12% of stake
May 13 – 14No plan
Keith A. Meister
Director · sold 329,460 at avg $145.49
$47.9M
8.6% of stake
May 610b5-1 plan
Christensen Jakob Wedel
SVP, Strategy/Corp Development · sold 700 at $139.04
97K
4.4% of stake
Feb 2010b5-1 plan
Scott M Davies
Chief Legal Officer · sold 1,336 at $116.18
155K
7.6% of stake
Feb 1810b5-1 plan
Patricia Leckman
SVP, Chief People Officer · sold 2,370 at $116.18
275K
13% of stake
Feb 9
Scott Gottlieb
Director · bought 200 at $117.81
24K
1.6% of stake
Dec 12, 202510b5-1 plan
Scott M Davies
Chief Legal Officer · sold 323 at $136.09
44K
1.8% of stake
Dec 8, 202510b5-1 plan
Christensen Jakob Wedel
SVP, Strategy/Corp Development · sold 549 at $129.27
71K
4.8% of stake
Nov 3, 2025
Scott Gottlieb
Director · bought 500 at $122.13
61K
4.2% of stake
May 12, 2025 – May 13, 2025
Jacob Thaysen
Chief Executive Officer · bought 12,350 at avg $80.86
999K
17% of stake
May 12, 2025
Ankur Dhingra
SVP, Chief Financial Officer · bought 6,100 at $81.21
495K
32% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ILMN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with ILMN

CompareIntrinsic value

WATWaters Corporation

$467.60+1.67%25

MTDMettler-Toledo International Inc.

$1,723.24+1.48%41

BRKRBruker Corporation

$63.79+12.90%23

RVTYRevvity Inc.

$159.44-2.47%20

BIOBio-Rad Laboratories Inc.

$379.99+1.35%48

AVTRAvantor Inc.

$15.65+0.38%22

AAgilent Technologies Inc.

$177.17+0.97%44

TXG10x Genomics Inc.

$67.52+3.42%48

Held by ETFs

ILMN is in 252 US ETFs. The largest of them, with ILMN's weight in each:

Spot a number that looks wrong? Check it in ILMN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ILMN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.